Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
10,470,510
-
Share change
-
+8,593,355
-
Total reported value
-
$93,712,000
-
Price per share
-
$8.95
-
Number of holders
-
16
-
Value change
-
+$77,212,478
-
Number of buys
-
14
-
Number of sells
-
2
Institutional Holders of INTEC PHARMA LTD JERUSALEM - SHS as of Q3 2017
As of 30 Sep 2017,
INTEC PHARMA LTD JERUSALEM - SHS was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,470,510 shares.
The largest 10 holders included
ACUTA CAPITAL PARTNERS, LLC, venBio Select Advisor LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., EcoR1 Capital, LLC, Cormorant Asset Management, LLC, Migdal Insurance & Financial Holdings Ltd., Sectoral Asset Management Inc, NEXTHERA CAPITAL LP, PURA VIDA INVESTMENTS, LLC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.